Efficacy of the VIRTUE male quadratic sling in the treatment of stress urinary incontinence: A retrospective study.


Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 31 03 2019
revised: 24 06 2019
accepted: 02 07 2019
pubmed: 8 8 2019
medline: 23 2 2020
entrez: 8 8 2019
Statut: ppublish

Résumé

To assess the efficacy and the impact on the quality of life (QoL) of patients suffering stress urinary incontinence (SUI) treated with VIRTUE © sling. Retrospective monocenteric study where patients treated with VIRTUE © sling were included between January 2016 and May 2018. The severity of the incontinence was judged based on the number of protection used per day (PPD) and/or on the 24hours pad test into mild, moderate and severe: ≥2 protections and/or <100ml/24h, 3-4 protections and/or 101-200ml/24h, >4 protections and/or>200ml/24h respectively. The criteria of success was achieved when the patient is dry or ameliorated. The ICIQ- UI sf questionnaire was used as a measure of QoL. Thirty-five patients were included in this study with mean follow up time of 11 months (range: 3-26). Twenty-nine patients had a radical prostatectomy, 3 had endoscopic treatment for benign prostatic hyperplasia, 9 patient had radiotherapy of which one had a complementary focal treatment (HIFU), and two patients had spinal cord injury. The success rate was 83%. The score ICIQ-UI sf showed a statistical difference between the pre and post-operative periods in both success and failure groups (P<0.001). History of radiotherapy, low bladder compliance, and severe incontinence were associated with negative result. Pain was the most recorded post-operative complication and no>grade 2 Clavien Dindo complications were encountered. The VIRTUE © sling seems to be an effective, safe tool treating SUI at short term. 3.

Identifiants

pubmed: 31387835
pii: S1166-7087(19)30162-9
doi: 10.1016/j.purol.2019.07.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

490-495

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

A Abdullah (A)

Service de chirurgie urologique et andrologique, CHU de Limoges, 2, avenue de Martin Luther-King, 87100 Limoges, France; Department of surgery (Urology unit), Al-Amiri hospital, Kuwait City, Kuwait. Electronic address: draliabdullah85@hotmail.com.

F Machkour (F)

Service de chirurgie urologique et andrologique, CHU de Limoges, 2, avenue de Martin Luther-King, 87100 Limoges, France.

E Bouchet (E)

Service de chirurgie urologique et andrologique, CHU de Limoges, 2, avenue de Martin Luther-King, 87100 Limoges, France.

X Plainard (X)

Service de chirurgie urologique et andrologique, CHU de Limoges, 2, avenue de Martin Luther-King, 87100 Limoges, France.

A Descazeaud (A)

Service de chirurgie urologique et andrologique, CHU de Limoges, 2, avenue de Martin Luther-King, 87100 Limoges, France. Electronic address: aureliendescazeaud@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH